Advisors Capital Management »

United Therapeutics Corporation shares owned by Advisors Capital Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Advisors Capital Management from 13F filings

Historical chart of Advisors Capital Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Advisors Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Advisors Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $329k 918 358.39

More positions owned by Advisors Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Blackstone Group Inc Com Cl A (BX)
NVIDIA Corporation (NVDA)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
International Business Machines (IBM)
Chevron Corporation (CVX)
Philip Morris International (PM)
Qualcomm (QCOM)
Ares Capital Corporation (ARCC)
Thermo Fisher Scientific (TMO)

View all positions for Advisors Capital Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation